Tumor-targeted photodynamic medicine carrying nanoparticle as well as preparation method and application thereof
A drug-loaded nano- and tumor-targeting technology, which is applied in the direction of anti-tumor drugs, pharmaceutical formulations, and medical preparations with non-active ingredients, can solve the problems of poor targeting ability and chemotherapy resistance, and achieve the reduction of inhibitory concentration, The effect of reversing chemotherapy drug resistance and efficiently targeting tumors
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0054] The preparation method of the tumor-targeted photodynamic drug-loaded nanoparticles has a conjugated structure chemotherapy drug of doxorubicin, or epirubicin, or mitoxantrone.
[0055] In the preparation method of the tumor-targeted photodynamic drug-loaded nanoparticles, the porphyrin or its derivatives are protoporphyrin, or hematoporphyrin, or uroporphyrin, or coproporphyrin.
[0056] The preparation method of the tumor-targeted photodynamic drug-loaded nanoparticle, the molecular weight of the two-terminal amino-terminated isopropyl polyethylene glycol is 2000-6000Da.
[0057] In the preparation method of the tumor-targeted photodynamic drug-loaded nanoparticles, the mass ratio of the chemotherapeutic drug with a conjugated structure to the nano drug carrier is 8:1-1:8.
[0058] In the preparation method of the tumor-targeted photodynamic drug-loaded nanoparticles, the molar ratio of the EDC and NHS of the carboxyl activating group to the carboxyl unit in porphyrin...
Embodiment 1
[0064] 1. Synthesis of hematoporphyrin-polyethylene glycol (HPP) nano drug carrier
[0065] Weigh 22 mg hematoporphyrin, dissolve in 22 mL 2-morpholineethanesulfonic acid (MES) (200 mM, pH=6.0) buffer, stir overnight at room temperature; add 12.6 mg 1-ethyl-(3-dimethylaminopropyl base) carbodiimide hydrochloride (EDC), 7.6 mg N-hydroxysuccinimide (NHS), wherein, the molar ratio of EDC, NHS of the carboxyl activating group to the carboxyl unit in porphyrin or its derivatives is 1:1, activate at room temperature for 5-6h, add 28uL 2-mercaptoethanol to quench EDC;
[0066] Weigh 60 mg of isopropyl polyethylene glycol (NH 2 -PEG-NH 2 ) (molecular weight of 1500) was dissolved in 10 mL of 200 mM phosphate buffer saline (PBS) (200mM, pH =7.5~8.0), the step Use NaOH (1M) to quickly adjust the pH value of the middle solution to 7.5~8.0, transfer it into a constant pressure dropping funnel, control the dropping speed (10s / drop), stir and react overnight, and dialyze with bori...
Embodiment 2
[0091] Synthesis of hematoporphyrin-polyethylene glycol (HPP) nano drug carrier
[0092] Weigh 11 mg of hematoporphyrin, dissolve in 22 mL of MES (200 mM, pH=6.0) buffer, and stir overnight at room temperature. Add 12.6 mg EDC, 7.6 mg NHS and activate at room temperature for 5-6 hours, wherein the molar ratio of EDC, NHS and carboxyl units in porphyrin or its derivatives of the carboxyl activation group is 2:1, add 15 μL 2-mercaptoethanol to quench Extinguish EDC;
[0093] Weigh 30 mg NH2-PEG-NH2 (molecular weight 2500) and dissolve in 10 mL 200 mM PB buffer (200mM, pH =7.5~8.0), and Use NaOH (1M) to quickly adjust the pH value of the middle solution to 7.5~8.0, transfer it into a constant pressure dropping funnel, control the dropping speed (10s / drop), stir and react overnight, and dialyze with boric acid buffer (200mM, pH= 8.5) for 48h (retention Molecular weight 3000 Da). Aqueous dispersion of HPP nanoparticles was obtained. The dispersion was freeze-dried to obt...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com